176 related articles for article (PubMed ID: 33465364)
1. Improving the inhibition of β-amyloid aggregation by withanolide and withanoside derivatives.
Dubey S; Kallubai M; Subramanyam R
Int J Biol Macromol; 2021 Mar; 173():56-65. PubMed ID: 33465364
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the active interaction mechanism of phytochemicals withanolide and withanoside derivatives with human serum albumin.
Dubey S; Kallubai M; Sarkar A; Subramanyam R
PLoS One; 2018; 13(11):e0200053. PubMed ID: 30403672
[TBL] [Abstract][Full Text] [Related]
3. β-Amyloid1-42, HIV-1Ba-L (clade B) infection and drugs of abuse induced degeneration in human neuronal cells and protective effects of ashwagandha (Withania somnifera) and its constituent Withanolide A.
Kurapati KR; Samikkannu T; Atluri VS; Kaftanovskaya E; Yndart A; Nair MP
PLoS One; 2014; 9(11):e112818. PubMed ID: 25415340
[TBL] [Abstract][Full Text] [Related]
4. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
5. Withanolides from
Khanal P; Chikhale R; Dey YN; Pasha I; Chand S; Gurav N; Ayyanar M; Patil BM; Gurav S
J Biomol Struct Dyn; 2022 Aug; 40(12):5295-5308. PubMed ID: 33459174
[TBL] [Abstract][Full Text] [Related]
6. Ashwagandha (Withania somnifera) reverses β-amyloid1-42 induced toxicity in human neuronal cells: implications in HIV-associated neurocognitive disorders (HAND).
Kurapati KR; Atluri VS; Samikkannu T; Nair MP
PLoS One; 2013; 8(10):e77624. PubMed ID: 24147038
[TBL] [Abstract][Full Text] [Related]
7. 1,2,4-trihydroxynaphthalene-2-O-β-D-glucopyranoside delays amyloid-β
Dhouafli Z; Leri M; Bucciantini M; Stefani M; Gadhoumi H; Mahjoub B; Ben Jannet H; Guillard J; Ksouri R; Saidani Tounsi M; Soto C; Hayouni EA
Biofactors; 2018 May; 44(3):272-280. PubMed ID: 29582494
[TBL] [Abstract][Full Text] [Related]
8. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
Trivedi MK; Panda P; Sethi KK; Jana S
Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
[TBL] [Abstract][Full Text] [Related]
9. Identification of a Novel Multifunctional Ligand for Simultaneous Inhibition of Amyloid-Beta (Aβ
Asadbegi M; Shamloo A
ACS Chem Neurosci; 2019 Nov; 10(11):4619-4632. PubMed ID: 31566950
[TBL] [Abstract][Full Text] [Related]
10. Subcritical water extraction of withanosides and withanolides from ashwagandha (Withania somnifera L) and their biological activities.
Nile SH; Nile A; Gansukh E; Baskar V; Kai G
Food Chem Toxicol; 2019 Oct; 132():110659. PubMed ID: 31276745
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
[TBL] [Abstract][Full Text] [Related]
12. [Overcoming several neurodegenerative diseases by traditional medicines: the development of therapeutic medicines and unraveling pathophysiological mechanisms].
Tohda C
Yakugaku Zasshi; 2008 Aug; 128(8):1159-67. PubMed ID: 18670181
[TBL] [Abstract][Full Text] [Related]
13. Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study.
Doytchinova I; Atanasova M; Salamanova E; Ivanov S; Dimitrov I
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32942739
[TBL] [Abstract][Full Text] [Related]
14. Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities.
Zhao J; Nakamura N; Hattori M; Kuboyama T; Tohda C; Komatsu K
Chem Pharm Bull (Tokyo); 2002 Jun; 50(6):760-5. PubMed ID: 12045329
[TBL] [Abstract][Full Text] [Related]
15. Molecular dynamics simulation of bioactive compounds of
Begum S; Shadrack DM; Joseph FM; Ndensendo VMK
J Biomol Struct Dyn; 2022; 40(19):9279-9286. PubMed ID: 34018468
[TBL] [Abstract][Full Text] [Related]
16. Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration.
Kuboyama T; Tohda C; Komatsu K
Eur J Neurosci; 2006 Mar; 23(6):1417-26. PubMed ID: 16553605
[TBL] [Abstract][Full Text] [Related]
17. RTHLVFFARK-NH
Meng J; Zhang H; Dong X; Liu F; Sun Y
J Inorg Biochem; 2018 Apr; 181():56-64. PubMed ID: 29407908
[TBL] [Abstract][Full Text] [Related]
18. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
Dai X; Hou W; Sun Y; Gao Z; Zhu S; Jiang Z
Int J Mol Sci; 2015 May; 16(5):10526-36. PubMed ID: 26006224
[TBL] [Abstract][Full Text] [Related]
19. β-sheet breakers with consecutive phenylalanines: Insights into mechanism of dissolution of β-amyloid fibrils.
Jarmuła A; Ludwiczak J; Stępkowski D
Proteins; 2021 Jul; 89(7):762-780. PubMed ID: 33550630
[TBL] [Abstract][Full Text] [Related]
20. Searching for improved mimetic peptides inhibitors preventing conformational transition of amyloid-β
Gera J; Szögi T; Bozsó Z; Fülöp L; Barrera EE; Rodriguez AM; Méndez L; Delpiccolo CML; Mata EG; Cioffi F; Broersen K; Paragi G; Enriz RD
Bioorg Chem; 2018 Dec; 81():211-221. PubMed ID: 30144634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
